|
1
|
Weitz J, Koch M, Debus J, Höhler T, Galle
PR and Büchler MW: Colorectal cancer. Lancet. 365:153–165. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Walker MS, Pharm EY, Kerr J, Yim YM,
Stepanski EJ and Schwartzberg LS: Symptom burden & quality of
life among patients receiving second-line treatment of metastatic
colorectal cancer. BMC Res Notes. 5:3142012. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Andreu M, Marzo M, Mascort J, Quintero E,
García-Alfonso P, López-Ibor C, Castells T and Pérez Segura P:
Colorectal cancer prevention. Clin Transl Oncol. 11:65–66. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Center MM, Jemal A and Ward E:
International trends in colorectal cancer incidence rates. Cancer
Epidemiol Biomarkers Prev. 18:1688–1694. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Mcguire S: World Cancer Report 2014.
Geneva, Switzerland: World Health Organization, international
agency for research on cancer, WHO press, 2015. Adv Nutr.
7:4182016. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Como JA, Mahendraraj K, Lau CS and
Chamberlain RS: Adenosquamous carcinoma of the colon and rectum: A
population based clinical outcomes study involving 578 patients
from the Surveillance Epidemiology and End Result (SEER) database
(1973–2010). J Am Coll Surg. 221:e562015. View Article : Google Scholar
|
|
7
|
Bray F, Ferlay J, Soerjomataram I, Siegel
RL, Torre LA and Jemal A: Global cancer statistics 2018: GLOBOCAN
estimates of incidence and mortality worldwide for 36 cancers in
185 countries. CA Cancer J Clin. 68:394–424. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Pallante P, Terracciano L, Carafa V,
Schneider S, Zlobec I, Lugli A, Bianco M, Ferraro A, Sacchetti S,
Troncone G, et al: The loss of the CBX7 gene expression represents
an adverse prognostic marker for survival of colon carcinoma
patients. Eur J Cancer. 46:2304–2313. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Kim YJ, Kang HB, Yim HS, Kim JH and Kim
JW: NDRG2 positively regulates E-cadherin expression and prolongs
overall survival in colon cancer patients. Oncol Rep. 30:1890–1898.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Kim YJ, Yoon SY, Kim JT, Choi SC, Lim JS,
Kim JH, Song EY, Lee HG, Choi I and Kim JW: NDRG2 suppresses cell
proliferation through down-regulation of AP-1 activity in human
colon carcinoma cells. Int J Cancer. 124:7–15. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Miyoshi N, Yamamoto H, Mimori K, Yamashita
S, Miyazaki S, Nakagawa S, Ishii H, Noura S, Ohue M, Yano M, et al:
ANXA9 gene expression in colorectal cancer: A novel marker for
prognosis. Oncol Lett. 8:2313–2317. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Kontos CK, Papadopoulos IN and Scorilas A:
Quantitative expression analysis and prognostic significance of the
novel apoptosis-related gene BCL2L12 in colon cancer. Biol Chem.
389:1467–1475. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Zhan J, Niu M, Wang P, Zhu X, Li S, Song
J, He H, Wang Y, Xue L, Fang W and Zhang H: Elevated HOXB9
expression promotes differentiation and predicts a favourable
outcome in colon adenocarcinoma patients. Br J Cancer. 111:883–893.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Maekawa S, Suzuki A, Sugano S and Suzuki
Y: RNA sequencing: From sample preparation to analysis. Methods Mol
Biol. 1164:51–65. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Servant N, Roméjon J, Gestraud P, La Rosa
P, Lucotte G, Lair S, Bernard V, Zeitouni B, Coffin F,
Jules-Clément G, et al: Bioinformatics for precision medicine in
oncology: Principles and application to the SHIVA clinical trial.
Front Genet. 5:1522014. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Colaprico A, Silva TC, Olsen C, Garofano
L, Cava C, Garolini D, Sabedot TS, Malta TM, Pagnotta SM,
Castiglioni I, et al: TCGAbiolinks: An R/Bioconductor package for
integrative analysis of TCGA data. Nucleic Acids Res. 44:e712015.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Ritchie ME, Phipson B, Wu D, Hu Y, Law CW,
Shi W and Smyth GK: limma powers differential expression analyses
for RNA-sequencing and microarray studies. Nucleic Acids Res.
43:e472015. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Lindblom A: Improved tumor staging in
colorectal cancer. N Engl J Med. 339:264–265. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Huntley R, Dimmer E, Barrell D, Binns D
and Apweiler R: The Gene Ontology Annotation (GOA) database. Nat
Preced. 10:429–438. 2009.
|
|
20
|
Kanehisa M and Goto S: KEGG: Kyoto
encyclopedia of genes and genomes. Nucleic Acids Res. 27:29–34.
2000.
|
|
21
|
Yu G, Wang LG, Han Y and He QY:
clusterProfiler: An R package for comparing biological themes among
gene clusters. OMICS. 16:284–287. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Luo W and Brouwer C: Pathview: An
R/Bioconductor package for pathway-based data integration and
visualization. Bioinformatics. 29:1830–1831. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Stel VS, Dekker FW, Tripepi G, Zoccali C
and Jager KJ: Survival analysis I: The Kaplan-Meier method. Nephr
Clin Pract. 119:c255–c260. 2011. View Article : Google Scholar
|
|
24
|
Szklarczyk D, Morris JH, Cook H, Kuhn M,
Wyder S, Simonovic M, Santos A, Doncheva NT, Roth A, Bork P, et al:
The STRING database in 2017: Quality-controlled protein-protein
association networks, made broadly accessible. Nucleic Acids Res 45
(Database Issue). D362–D368. 2017. View Article : Google Scholar
|
|
25
|
Kohl M, Wiese S and Warscheid B:
Cytoscape: Software for visualization and analysis of biological
networks. Methods Mol Biol. 696:291–303. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Morán A, Iniesta P, García-Aranda C, De
Juan C, Díaz-López A, Sánchez-Pernaute A, Torres AJ, Díaz-Rubio E,
Balibrea JL and Benito M: Clinical relevance of MMP-9, MMP-2,
TIMP-1 and TIMP-2 in colorectal cancer. Oncol Rep. 13:115–120.
2005.PubMed/NCBI
|
|
27
|
Işlekel H, Oktay G, Terzi C, Canda AE,
Füzün M and Küpelioğlu A: Matrix metalloproteinase-9, −3 and tissue
inhibitor of matrix metalloproteinase-1 in colorectal cancer:
Relationship to clinicopathological variables. Cell Biochem Funct.
25:433–441. 2007. View
Article : Google Scholar : PubMed/NCBI
|
|
28
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Song G, Xu S, Zhang H, Wang Y, Xiao C,
Jiang T, Wu L, Zhang T, Sun X, Zhong L, et al: TIMP1 is a
prognostic marker for the progression and metastasis of colon
cancer through FAK-PI3K/AKT and MAPK pathway. J Exp Clin Cancer
Res. 35:1482016. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Birgisson H, Nielsen HJ, Christensen IJ,
Glimelius B and Brünner N: Preoperative plasma TIMP-1 is an
independent prognostic indicator in patients with primary
colorectal cancer: A prospective validation study. Eur J Cancer.
46:3323–3331. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Nielsen HJ, Brünner N, Jorgensen LN, Olsen
J, Rahr HB, Thygesen K, Hoyer U, Laurberg S, Stieber P,
Blankenstein MA, et al: Plasma TIMP-1 and CEA in detection of
primary colorectal cancer: A prospective, population based study of
4509 high-risk individuals. Scand J Gastroenterol. 46:60–69. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Giaginis C, Nikiteas N, Margeli A,
Tzanakis N, Rallis G, Kouraklis G and Theocharis S: Serum tissue
inhibitor of metalloproteinase 1 and 2 (TIMP-1 and TIMP-2) levels
in colorectal cancer patients: Associations with
clinicopathological variables and patient survival. Int J Biol
Markers. 24:245–252. 2010. View Article : Google Scholar
|
|
33
|
Sui H, Xu H, Ji Q, Liu X, Zhou L, Song H,
Zhou X, Xu Y, Chen Z, Cai J, et al: 5-hydroxytryptamine receptor
(5-HT1DR) promotes colorectal cancer metastasis by regulating
Axin1/β-catenin/MMP-7 signaling pathway. Oncotarget. 6:25975–25987.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Ataee R, Ajdary S, Zarrindast M, Rezayat M
and Hayatbakhsh MR: Anti-mitogenic and apoptotic effects of 5-HT1B
receptor antagonist on HT29 colorectal cancer cell line. J Cancer
Res Clin Oncol. 136:1461–1469. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Mazzoccoli G, Pazienza V, Panza A, Valvano
MR, Benegiamo G, Vinciguerra M, Andriulli A and Piepoli A: ARNTL2
and SERPINE1: Potential biomarkers for tumor aggressiveness in
colorectal cancer. J Cancer Res Clin Oncol. 138:501–511. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Bergeron S, Lemieux E, Durand V, Cagnol S,
Carrier JC, Lussier JG, Boucher MJ and Rivard N: The serine
protease inhibitor serpinE2 is a novel target of ERK signaling
involved in human colorectal tumorigenesis. Mol Cancer. 9:2712010.
View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Bufu T, Di X, Yilin Z, Gege L, Xi C and
Ling W: Celastrol inhibits colorectal cancer cell proliferation and
migration through suppression of MMP3 and MMP7 by the PI3K/AKT
signaling pathway. Anticancer Drugs. 29:530–538. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Cianchi F, Papucci L, Schiavone N, Lulli
M, Magnelli L, Vinci MC, Messerini L, Manera C, Ronconi E,
Romagnani P, et al: Cannabinoid receptor activation induces
apoptosis through tumor necrosis factor alpha-mediated ceramide de
novo synthesis in colon cancer cells. Clin Cancer Res.
14:7691–7700. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Perna F, Bechi P, Perigli G, Manera C,
Schiavone N, Papucci L, Magnelli L, Masini M, Lulli M, Donnini M,
et al: Cannabinoids induces apoptosis in human colon cancer cells
via CB2 receptor activation. Dig Liver Dis. 38 (Suppl 1):S107–S108.
2006. View Article : Google Scholar
|
|
40
|
Martínez-Martínez E, Gómez I, Martín P,
Sánchez A, Román L, Tejerina E, Bonilla F, Merino AG, de Herreros
AG, Provencio M and García JM: Cannabinoids receptor type 2, CB2,
expression correlates with human colon cancer progression and
predicts patient survival. Oncoscience. 2:131–141. 2015. View Article : Google Scholar : PubMed/NCBI
|
